IMRX,Immuneering Corporation | Healthcare

Healthcare

IMRX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Immuneering CorporationIMRX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients.

Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 currently in Investigational New Drug application to treat solid tumors.

Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

Latest News >

Novartis' Pluvicto shown to slow prostate cancer in earlier setting

Jun 2, 2025

FRANKFURT (Reuters) -Novartis said on Monday that its targeted radiotherapy Pluvicto was shown to slow progression of a certain type of prostate cancer, raising the prospect of treatment in an earlier disease stage for a drug technology that the drugmaker has pioneered. The Swiss drugmaker reported a late-stage trial showed a clinically meaningful benefit in progression-free survival with a positive...

Tesla's sales in Sweden fall 53.7% year-on-year in May

Jun 2, 2025

STOCKHOLM (Reuters) -Tesla's new car sales in Sweden fell 53.7% in May from a year earlier to 503 vehicles, registration data from Mobility Sweden showed on Monday. ...

Japan's Nikkei ends lower on worries about US-China trade tension, stronger yen

Jun 2, 2025

(Updates with closing prices) TOKYO, June 2 (Reuters) - Japan's Nikkei share average ended lower on Monday amid worries over trade tensions between the U.S. and China, and a stronger yen, which hurt automakers. The Nikkei fell 1.3% to 37,470.67 and the broader Topix slipped 0.87% to 2777.29. Investors were worried about rising uncertainties about trade issues, said Shoichi Arisawa,...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...